argenx SE | Investor Presentation Deck | 26 slides

argenx · 2023-08
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON

Slide inventory

26
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detailBeat · Setup
02
front_matter
Open slide detailBeat · Setup
03
The slide uses a high-level mission statement as the primary anchor for the presentation.establish_context
Open slide detailBeat · Setup
04
The slide uses a patient persona (Crystal) to humanize the clinical goals of minimizing burden and restoring quality of life.illustrate_case
Open slide detailBeat · Setup
05
establish_context
Open slide detailBeat · Setup
06
The slide uses a hub-and-spoke visual arrangement with a central image of a patient.summarize
Open slide detailBeat · WhatLoop · Cost Of Inaction
07
The slide uses a central circular image overlaying four surrounding text boxes containing key performance indicators.summarize
Open slide detailBeat · WhatLoop · Cost Of Inaction
08
The slide uses a circular, iterative process diagram to suggest continuous growth.present_framework
Open slide detailBeat · WhatLoop · Cost Of Inaction
09
The slide uses a 3D-like coordinate system to show expansion vectors.plan_implementation
Open slide detailBeat · WhatLoop · Cost Of Inaction
10
The slide uses a map to visualize global reach, supplemented by two tables detailing approval dates for two different products.establish_context
Open slide detailBeat · WhatLoop · Cost Of Inaction
11
The slide uses a hub-and-spoke visual metaphor to link the drug class to various autoantibody targets.establish_context
Open slide detailBeat · The GoalLoop · Quick Win Big Bet
12
The slide uses a pyramid structure to imply growth and scale across multiple disease areas.size_opportunity
Open slide detailBeat · The GoalLoop · Quick Win Big Bet
13
Kaplan-Meier curve shows probability of no relapse over 48 weeks for Vyvgart Hytrulo vs Placebo.analyze_data
Open slide detailBeat · The GoalLoop · Quick Win Big Bet
14
The slide uses a split-screen layout: left side details the mechanism of action and current status of the MMN study, right side details the future roadmap.plan_implementation
Open slide detailBeat · The GoalLoop · Quick Win Big Bet
15
Includes a biological mechanism diagram on the left and a clinical trial roadmap on the right.plan_implementation
Open slide detailBeat · The GoalLoop · Quick Win Big Bet
16
The slide uses a circular icon-based layout to categorize medical conditions under four main therapeutic areas.present_framework
Open slide detailBeat · The GoalLoop · Quick Win Big Bet
17
The slide uses a hub-and-spoke style layout to represent partnerships, though it is not a formal framework.other
Open slide detailBeat · Visualization
18
plan_implementation
Open slide detailBeat · Visualization
19
The slide uses a hub-and-spoke diagram to represent corporate values.summarize
Open slide detailBeat · Visualization
20
The chart uses a horizontal bar format to represent clinical trial phases (Preclinical to Commercial) for multiple indications under four main programs.plan_implementation
Open slide detailBeat · Visualization
21
Clinical trial design slide showing a timeline of visits and dosing phases.establish_context
Open slide detailBeat · Visualization
22
The slide outlines a clinical trial protocol using a timeline-based process flow.present_framework
Open slide detailBeat · Visualization
23
Clinical trial design schematic showing 2:1 randomization between Efgartigimod and Placebo over 24 weeks.present_framework
Open slide detailBeat · Resolution
24
The slide uses a process flow diagram to illustrate the clinical trial structure.present_framework
Open slide detailBeat · Resolution
25
The slide outlines a multi-phase trial structure with specific cohorts (IMNM, ASyS, DM) and a GO/NO-GO decision point.present_solution
Open slide detailBeat · Resolution
26
The slide uses a timeline-based process diagram to illustrate the clinical trial structure.present_framework
Open slide detailBeat · Resolution